医学
普罗帕酮
多非利特
弗莱卡奈德
伊布利特
索他洛尔
内科学
胺碘酮
心房颤动
奎尼丁
窦性心律
优势比
地高辛
心脏病学
置信区间
随机对照试验
抗心律失常药
心脏病
心力衰竭
作者
Marlene R. Miller,R L McNamara,J. B. Segal,Nick H. Kim,K A Robinson,Steven N. Goodman,N R Powe,Eric B Bass
出处
期刊:PubMed
日期:2000-11-01
卷期号:49 (11): 1033-46
被引量:91
摘要
Although multiple antiarrhythmic agents had strong evidence of efficacy compared with control treatment for MSR, ibutilide/dofetilide and flecainide had particularly strong evidence of efficacy compared with control treatment for AF conversion. There is sparse and inconclusive evidence on direct agent comparisons and adverse event rates. Obtaining information regarding these relative efficacies should be a research priority.
科研通智能强力驱动
Strongly Powered by AbleSci AI